Kim, K., Ngo, D., Tinajero, J., Yang, D., Shan, H., Sandhu, K., Ali, H., Otoukesh, S., Amanam, I., Arslan, S., Agrawal, V., Park, S., Nakamura, R., Malki, M. M. A., Salhotra, A. (2025). Post-transplant cyclophosphamide-based graft-verses-host disease (GVHD) prophylaxis is associated with a low incidence of fibrotic chronic GVHD after allogeneic hematopoietic cell transplantation across diverse donor types. Blood. https://doi.org/10.1182/blood-2025-935